4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 
4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 

4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 

MOQ:5000pcs
PRODUCT DESCRIPTION
High Light:

heart disease blood test

,

diagnostic heart tests

Brand Name New Life
Certification ISO13485,CE
Delivery Time 20-30days
Minimum Order Quantity 5000pcs
View More
ABOUT US
Orient New Life Medical Co.,Ltd.
Orient New Life Medical Co.,Ltd. manufacturer profile
12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China ,China
5.0
Verified Supplier
View More
Get the Best Price for
4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 
4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 
MOQ: 5000pcs
Continue
Recommended Products
About Us
Orient New Life Medical Co.,Ltd.
Orient New Life Medical Co.,Ltd. manufacturer profile
12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China ,China
5.0
Verified Supplier
Company Name Orient New Life Medical Co.,Ltd.
Business Type: Manufacturer,Exporter
Brands: New Life
No. of Employees: 200~300
Year Established: 2009
Annual Sales: 10,000,000-15,000,000
Company Location 12F,Guting Building,Hefeng Creative Square,No.495 Jiangdong North Road,Ningbo,Zhejiang, China
Factory Location No.1369, Chengnan Road, Jiaxing, Zhejiang, China
China Orient New Life Medical Co.,Ltd. manufacturer profile
China Orient New Life Medical Co.,Ltd. manufacturer profile
China Orient New Life Medical Co.,Ltd. manufacturer profile

Established in 2009, Orient New Life Medical Co., Ltd., is specialized in high-tech biological diagnostic test development, research and production, as well as high-tech medical device development, research and production. New Life has built up two production base, which produce biological diagnostic test and endoscopic medical device respectively. Our products ranged in the following specialties: drug of abuse tests, fertility tests, infectious diseases tests, sexual transmitted diseases tests, tumor markers tests, cardiac markers tests, veterinary tests, and surgical stapler series.

 

NEW LIFE have 3 wholly-owned and joint stock subsidiary companies, including Orient New Life Medical  Co., Ltd., Orient Gene Biotech Co., Ltd., Qianjing Medical Equipment Co., Ltd.

 

Company's core technical team with more than 35 employees,3 doctors and 25 masters. They have many years of famous universities in the United States and pharmaceutical companies engaged in the project research and development, production and marketing, business management experience.Company owns hundreds of grade purification workshop and all level of quality checkout room, equipped with various production and testing equipment.

Get Latest Price For Your Requirement
PRODUCT DESCRIPTION
High Light:

heart disease blood test

,

diagnostic heart tests

Place of Origin China
Brand Name New Life
Certification ISO13485,CE
Model Number cassette
Minimum Order Quantity 5000pcs
Packaging Details 1pc/pouch, 25pcs/box
Delivery Time 20-30days
Payment Terms T/T, Western Union, MoneyGram
Supply Ability 2000000pcs/month
Category Cardiac
Format Device
Specimen WB/S/P
Testing time 10-15 minutes
Shelf Life 24 Months
Application cTnl test
Accuracy 99.1%

 

4mm Cassette Cardiac Blood Tests Cut - Off 1ng/Ml , Blood Tests For Heart Health 

Description:

High Sensitivity Troponin I cardiac blood test, professional use, 4mm cassette, cut-off 1ng/ml

 

 

Intended Use:

 

The Troponin I Rapid Test Device (Whole Blood/Serum/Plasma) is a rapid, two-site sandwich immunoassay for the detection of human cardiac Troponin I (cTnI) levels in human whole blood.

 

 

Summary:

 

Discovered by Ebashi, Troponins are regulatory proteins in cardiac muscle that modulate the interaction between actin and myosin, during the calcium-mediated contraction of cardiac muscle. Three distinct tissue specific isoforms of Troponin I have been identified, two in skeletal muscle and one in cardiac muscle. The cardiac isoform of Troponin I (cTnI) has an additional sequence of 31 amino acids at the N terminal end that accounts for cardiac specificity, with a molecular weight of 22.5 kDa. This absolute specificity of Troponin I for cardiac tissue makes it an ideal biomarker for myocardial injury. Clinical study results have demonstrated that elevated levels of cardiac Troponin I (cTnI) are detectable in blood stream within 4 to 6 hours after the onset of chest pain, reach peak concentration in approximately 12 hours and remain elevated for 3-10 days following acute myocardial infarction. Thus cardiac Troponin I (cTnI) meets all the criterion laid down by National Academy of Clinical Biochemistry (NACB) for an ideal cardiac biomarker in early identification and risk stratification of patients with chest pain suggestive of ischaemia and identification of patients that present after infarction.

 

 

Test Principle:

 

The Troponin I Rapid Test Device utilizes the principle of immunochromatography, with a unique two-site sandwich immunoassay on a nitrocellulose membrane. The conjugate pad contains two components-monoclonal anti-cTnI conjugated to colloidal gold and rabbit IgG conjugated to colloidal gold. As the test sample flows through the membrane assembly of the device, the highly specific anti-cTnI antibody - colloidal gold conjugate complexes with cTnI in the sample and travels on the membrane due to capillary action along with rabbit IgG-colloidal gold conjugate. This sample moves further on the membrane to the test region (T) where it is immobilized by another specific anti-cTnI antibody coated on the membrane leading to the formation of a pink-purple band. A detectable coloured band is formed if cTnI level is equal to or greater than 0.3 ng/ml. The absence of this coloured band in the test region indicates cTnI concentration < 0.3 ng/ml. The unreacted conjugate along with unbound complex if any, move further on the membrane and are subsequently immobilized by the anti-rabbit antibodies coated on the membrane at the control region (C) forming a pink-purple coloured band. The control band formation is based on the ‘Rabbit / anti-Rabbit globulin’ system. Since it is completely independent of the analyte detection system, it facilitates formation of consistent control band signal independent of the analyte concentration. This control band acts as a procedural control and serves to validate test results.

 

 

 

SPECIMEN COLLECTION AND PREPARATION

 

  1. WB uses human whole blood as specimen.
  2. No special preparation of the patient is necessary prior to specimen collection by approved techniques.
  3. Fresh anticoagulated whole blood should be used as test specimen. EDTA or Heparin or oxalate can be used as a suitable anticoagulant.
  4. Whole blood should be used immediately and should not be frozen. Do not use haemolysed, clotted or contaminated whole blood specimens.

 

INTERPRETATION OF RESULTS

 

POSITIVE:* Two lines appear. One colored line should be in the control line region (C) and another apparent colored line should be in the test line region (T).

 

*NOTE: The intensity of the color in the test line region (T) will vary depending on the concentration of TP antibodies present in the specimen. Therefore, any shade of color in the test line region (T) should be considered positive.

 

NEGATIVE: One colored line appears in the control line region (C). No line appears in the test line region (T).

 

INVALID: Control line fails to appear. Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for control line failure. Review the procedure and repeat the test with a new test. If the problem persists, discontinue using the test kit immediately and contact your local distributor.

 

 

 [#varpname#] 0

 

PERFORMANCE CHARACTERS:

 

 

Sensitivity and Specificity

 

The Troponin I Rapid Test Device (Whole Blood/Serum/Plasma) has been evaluated with a leading commercial cTnI EIA test using clinical specimens. The results show that the sensitivity of the Troponin I Rapid Test Device (Whole Blood/Serum/Plasma) is 98.3% and the specificity is 98.4% relative to the leading EIA test.

 

Troponin I Rapid Test Device vs. EIA

 

Method EIA Test

Total

Results

Troponin I Rapid Test Device Results Positive Negative
Positive 113 6 119
Negative 2 493 495
Total Results 115 499 614

 

Relative Sensitivity: 98.3%(93.9%-99.8%)*

 

Relative Specificity: 98.4%(97.4%-99.6%)*

 

Accuracy: 98.7%(97.5%-99.4%)*

*95% Confidence Interval

 

 

 
ORIENT NEW LIFE MEDICAL CO., LTD.
Contact: Jerry Meng
Email: Jerry @ newlifebiotest .com
Tel. +86 18657312116
SKYPE enetjerry

 

 

Get Latest Price For Your Requirement